The Leukaemia Research Fund is the only charity in the UK dedicated exclusively to researching blood cancers and disorders including leukaemia, Hodgkin's and other lymphomas, and myeloma. Leukaemia Research is introducing a Minimal Residual Disease (MRD) test – a revolutionary new way for doctors to determine which cancer patients are at risk of relapse and need more intensive treatment or a bone marrow transplant. However, if a patient is doing well, they can be spared the most toxic chemotherapy drugs. WOMAC is supporting the MRD Test with £20,000, which will provide 27 leukaemia patients with access to this potentially life-saving process.

For more details and to find out more about this charity please visit www.lrf.org.uk